Instadose Financial Statements From 2010 to 2026

INSD Stock  USD 0.0001  0.00  0.00%   
Instadose Pharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Instadose Pharma's valuation are provided below:
Market Capitalization
53.2 K
There are over eighty available fundamental trends for Instadose Pharma Corp, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Instadose Pharma's regular performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Working Capital is expected to grow to about (225.8 K). In addition to that, Enterprise Value is expected to decline to about 4.8 M
Check Instadose Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Instadose Pharma's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 557.9 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 1.6 K, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Instadose financial statements analysis is a perfect complement when working with Instadose Pharma Valuation or Volatility modules.
  
Build AI portfolio with Instadose Stock
Check out the analysis of Instadose Pharma Correlation against competitors.

Instadose Pharma Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities196 K186.6 K85.8 K
Slightly volatile
Net Debt36.3 K64 K35.2 K
Slightly volatile
Accounts Payable93.7 K89.2 K39 K
Slightly volatile
Common Stock Shares Outstanding82.5 M86.3 M76.1 M
Slightly volatile
Total Liabilities196 K186.6 K85.8 K
Slightly volatile
Short and Long Term Debt36.8 K64 K35.7 K
Slightly volatile
Common Stock6.4 K6.8 K47.1 K
Slightly volatile
Other Current Liabilities70.2 K97.4 K58.3 K
Slightly volatile
Capital Stock8.2 K8.6 K62.3 K
Slightly volatile
Cash And Short Term Investments52.058.563.8529
Slightly volatile
Common Stock Total Equity6.4 K6.8 K47.1 K
Slightly volatile
Liabilities And Stockholders Equity52.058.563.8529
Slightly volatile

Instadose Pharma Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative557.9 K531.3 K217.5 K
Slightly volatile

Instadose Pharma Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings398380175
Slightly volatile
Other Non Cash Items464.5 K442.4 K174.7 K
Slightly volatile
Change To Netincome464.5 K442.4 K174.7 K
Slightly volatile
Change To Operating Activities55 K61.9 K67.6 K
Slightly volatile
Cash Flows Other Operating98.8 K176.5 K76.7 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.6 K1.8 KK
Slightly volatile
Average Payables5.5 K5.2 K2.9 K
Slightly volatile
EV To Sales1.6 K1.9 KK
Slightly volatile
Payables Turnover1.381.561.7018
Slightly volatile
Sales General And Administrative To Revenue7.338.259.0001
Slightly volatile
Cash Per Share0.00.00.0033
Slightly volatile
Days Payables Outstanding169190207
Slightly volatile
Current Ratio4.0E-45.0E-41.6286
Slightly volatile
Revenue Per Share0.00.00.0
Slightly volatile
Interest Debt Per Share8.0E-49.0E-40.001
Slightly volatile
Debt To Assets623594358
Slightly volatile
Short Term Coverage Ratios0.0040.00450.0049
Slightly volatile
Days Of Payables Outstanding169190207
Slightly volatile
Ebt Per Ebit1.051.191.2865
Slightly volatile
Effective Tax Rate3.313.734.0692
Slightly volatile
Quick Ratio4.0E-45.0E-41.6286
Slightly volatile
Net Income Per E B T1.551.471.5066
Slightly volatile
Cash Ratio4.0E-45.0E-41.6286
Slightly volatile
Debt Ratio623594358
Slightly volatile
Price Sales Ratio1.6 K1.8 KK
Slightly volatile
Asset Turnover21.7224.4326.6706
Slightly volatile
Gross Profit Margin0.390.440.4824
Slightly volatile

Instadose Pharma Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap101.3 K114 K124.4 K
Slightly volatile
Enterprise Value4.8 M6.6 M4.6 M
Slightly volatile

About Instadose Pharma Financial Statements

Instadose Pharma stakeholders use historical fundamental indicators, such as Instadose Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Instadose Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Instadose Pharma's assets and liabilities are reflected in the revenues and expenses on Instadose Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Instadose Pharma Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sales General And Administrative To Revenue 8.25  7.33 
Ebit Per Revenue(5.88)(6.17)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Instadose Pharma Corp is a strong investment it is important to analyze Instadose Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instadose Pharma's future performance. For an informed investment choice regarding Instadose Stock, refer to the following important reports:
Check out the analysis of Instadose Pharma Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Will Pharmaceuticals sector continue expanding? Could Instadose diversify its offerings? Factors like these will boost the valuation of Instadose Pharma. Market participants price Instadose higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Instadose Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Return On Assets
(694.06)
Investors evaluate Instadose Pharma Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Instadose Pharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Instadose Pharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Instadose Pharma's market price signifies the transaction level at which participants voluntarily complete trades.